Palo Alto Investors »

Caredx shares owned by Palo Alto Investors

Quarter-by-quarter ownership of Caredx (CDNA) shares owned by Palo Alto Investors from 13F filings

Historical chart of Palo Alto Investors investment in Caredx

Tip: Access up to 7 years of quarterly data

All positions including Caredx held by Palo Alto Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Caredx by Palo Alto Investors

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.6M 316k 14.54

More positions owned by Palo Alto Investors

Insmed (INSM)
Ptc Therapeutics I (PTCT)
ACADIA Pharmaceuticals (ACAD)
Amicus Therapeutics (FOLD)
BioMarin Pharmaceutical (BMRN)
Biogen Sponsored Ads (BIIB)
United Therapeutics Corporation (UTHR)
Anaptysbio Inc Common (ANAB)
Iovance Biotherapeutics Com New (IOVA)
Novocure Ltd ord (NVCR)
Dyne Therapeutics Sponsored Ads (DYN)
Disc Medicine (IRON)
Alnylam Pharmaceuticals (ALNY)
Gossamer Bio (GOSS)
Prothena Corp Com Cl A (PRTA)

View all positions for Palo Alto Investors

Top funds holding Caredx

BlackRock
Vanguard Group
Bamco
State Street Corporation
Ophir Asset Management Pty
Deerfield Management Company
Braidwell
ARK Investment Management
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Gagnon Securities
Geode Capital Management
Dimensional Fund Advisors
Renaissance Technologies
Connor, Clark & Lunn Investment Management

View all funds holding Caredx